Trillium Therapeutics Raises Third Round

Trillium Therapeutics Inc., a Toronto-based drug company focused on immune-mediated disorders has raised C$12 million in third-round funding. Return backers include VenGrowth Private Equity Partners, BDC Capital and Canadian Medical Discoveries Fund (CMDF).

North AmericaUSBriefs